首页> 美国卫生研究院文献>Frontiers in Genetics >Defying c-Abl signaling circuits through small allosteric compounds
【2h】

Defying c-Abl signaling circuits through small allosteric compounds

机译:通过小的变构化合物对抗c-Abl信号传导回路

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many extracellular and intracellular signals promote the c-Abl tyrosine kinase activity. c-Abl in turn triggers a multitude of changes either in protein phosphorylation or in gene expression in the cell. Yet, c-Abl takes part in diverse signaling routes because of several domains linked to its catalytic core. Complex conformational changes turn on and off its kinase activity. These changes affect surface features of the c-Abl kinase and likely its capability to bind actin and/or DNA. Two specific inhibitors (ATP-competitive or allosteric compounds) regulate the c-Abl kinase through different mechanisms. NMR studies show that a c-Abl fragment (SH3–SH2-linker–SH1) adopts different conformational states upon binding to each inhibitor. This supports an unconventional use for allosteric compounds to unraveling physiological c-Abl signaling circuits.
机译:许多细胞外和细胞内信号促进c-Abl酪氨酸激酶活性。 c-Abl依次触发细胞中蛋白质磷酸化或基因表达的多种变化。然而,由于c-Abl与其催化核心相连的多个域,它参与了多种信号传导途径。复杂的构象变化可开启和关闭其激酶活性。这些变化影响c-Abl激酶的表面特征,并可能影响其结合肌动蛋白和/或DNA的能力。两种特异性抑制剂(ATP竞争性或变构化合物)通过不同的机制调节c-Abl激酶。核磁共振研究表明,c-Abl片段(SH3-SH2-接头-SH1)与每种抑制剂结合后会采用不同的构象状态。这支持了变构化合物的非常规用途,以揭示生理学c-Abl信号回路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号